148 related articles for article (PubMed ID: 25210277)
1. (175)Yb-TTHMP as a good candidate for bone pain palliation and substitute of other radiopharmaceuticals.
Safarzadeh L
Indian J Nucl Med; 2014 Jul; 29(3):135-9. PubMed ID: 25210277
[TBL] [Abstract][Full Text] [Related]
2. Production, biodistribution assessment and dosimetric evaluation of (177)Lu-TTHMP as an agent for bone pain palliation.
Zolghadri S; Yousefnia H; Jalilian AR; Ghannadi-Maragheh M
Asia Ocean J Nucl Med Biol; 2015; 3(1):35-42. PubMed ID: 27408879
[TBL] [Abstract][Full Text] [Related]
3. Feasibility study for production and quality control of Yb-175 as a byproduct of no carrier added Lu-177 preparation for radiolabeling of DOTMP.
Salek N; Shirvani Arani S; Bahrami Samani A; Vosoghi S; Mehrabi M
Australas Phys Eng Sci Med; 2018 Mar; 41(1):69-79. PubMed ID: 29260406
[TBL] [Abstract][Full Text] [Related]
4. Radiolabeling, stability studies, and pharmacokinetic evaluation of thulium-170-labeled acyclic and cyclic polyaminopolyphosphonic acids.
Vats K; Das T; Sarma HD; Banerjee S; Pillai MR
Cancer Biother Radiopharm; 2013 Dec; 28(10):737-45. PubMed ID: 23931111
[TBL] [Abstract][Full Text] [Related]
5. (170)Tm-EDTMP: a potential cost-effective alternative to (89)SrCl(2) for bone pain palliation.
Das T; Chakraborty S; Sarma HD; Tandon P; Banerjee S; Venkatesh M; Pillai MR
Nucl Med Biol; 2009 Jul; 36(5):561-8. PubMed ID: 19520297
[TBL] [Abstract][Full Text] [Related]
6. 175Yb labeled polyaminophosphonates as potential agents for bone pain palliation.
Mathew B; Chakraborty S; Das T; Sarma HD; Banerjee S; Samuel G; Venkatesh M; Pillai MR
Appl Radiat Isot; 2004 May; 60(5):635-42. PubMed ID: 15082040
[TBL] [Abstract][Full Text] [Related]
7. 177Lu labelled polyaminophosphonates as potential agents for bone pain palliation.
Chakraborty S; Das T; Unni PR; Sarma HD; Samuel G; Banerjee S; Venkatesh M; Ramamoorthy N; Pillai MR
Nucl Med Commun; 2002 Jan; 23(1):67-74. PubMed ID: 11748440
[TBL] [Abstract][Full Text] [Related]
8. Production and quality control 177Lu (NCA)-DOTMP as a potential agent for bone pain palliation.
Salek N; Shamsaei M; Ghannadi Maragheh M; Shirvani Arani S; Bahrami Samani A
J Appl Clin Med Phys; 2016 Nov; 17(6):128-139. PubMed ID: 27929488
[TBL] [Abstract][Full Text] [Related]
9. Production, Quality Control and Pharmacokinetic Studies of (177)Lu-EDTMP for Human Bone Pain Palliation Therapy Trials.
Bahrami-Samani A; Anvari A; Jalilian AR; Shirvani-Arani S; Yousefnia H; Aghamiri MR; Ghannadi-Maragheh M
Iran J Pharm Res; 2012; 11(1):137-44. PubMed ID: 25317195
[TBL] [Abstract][Full Text] [Related]
10. Preparation and biological evaluation of 153Sm-DOTMP as a potential agent for bone pain palliation.
Chakraborty S; Das T; Banerjee S; Chaudhari PR; Sarma HD; Venkatesh M; Pillai MR
Nucl Med Commun; 2004 Dec; 25(12):1169-76. PubMed ID: 15640774
[TBL] [Abstract][Full Text] [Related]
11. Production, quality control, and bio-distribution studies of (159)Gd-EDTMP as a palliative agent for bone pain.
Arani SS; Ghasemi S; Samani AB; Zafarghandi MS
Electron Physician; 2015; 7(1):977-84. PubMed ID: 26052408
[TBL] [Abstract][Full Text] [Related]
12. Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent.
Máthé D; Balogh L; Polyák A; Király R; Márián T; Pawlak D; Zaknun JJ; Pillai MR; Jánoki GA
Nucl Med Biol; 2010 Feb; 37(2):215-26. PubMed ID: 20152721
[TBL] [Abstract][Full Text] [Related]
13. 177Lu-EDTMP: a viable bone pain palliative in skeletal metastasis.
Chakraborty S; Das T; Banerjee S; Balogh L; Chaudhari PR; Sarma HD; Polyák A; Máthé D; Venkatesh M; Janoki G; Pillai MR
Cancer Biother Radiopharm; 2008 Apr; 23(2):202-13. PubMed ID: 18454689
[TBL] [Abstract][Full Text] [Related]
14. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
[TBL] [Abstract][Full Text] [Related]
15. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
[TBL] [Abstract][Full Text] [Related]
16. Absorbed dose assessment of (177)Lu-zoledronate and (177)Lu-EDTMP for human based on biodistribution data in rats.
Yousefnia H; Zolghadri S; Jalilian AR
J Med Phys; 2015; 40(2):102-8. PubMed ID: 26170557
[TBL] [Abstract][Full Text] [Related]
17. Production, quality control, biodistribution assessment and preliminary dose evaluation of (177)Lu-PDTMP as a possible bone palliative agent.
Yousefnia H; Jalilian AR; Zolghadri S; Ghannadi-Maragheh M
Nucl Med Commun; 2014 Jan; 35(1):99-107. PubMed ID: 24162837
[TBL] [Abstract][Full Text] [Related]
18. Preliminary dosimetric evaluation of (166)Ho-TTHMP for human based on biodistribution data in rats.
Yousefnia H; Zolghadri S; Jalilian AR; Tajik M; Ghannadi-Maragheh M
Appl Radiat Isot; 2014 Dec; 94():260-265. PubMed ID: 25255303
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
